GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | +10.8% | 1,271 | +20.5% | 0.01% | +20.0% |
| Q1 2022 | $37,000 | +19.4% | 1,055 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $31,000 | +19.2% | 1,055 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $26,000 | -25.7% | 1,055 | +5.2% | 0.00% | -40.0% |
| Q2 2021 | $35,000 | -86.7% | 1,003 | -84.5% | 0.01% | -86.8% |
| Q1 2021 | $263,000 | +2.3% | 6,462 | +8.9% | 0.04% | -7.3% |
| Q4 2020 | $257,000 | – | 5,935 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |